Concordance analysis of IHC and FISH in the detection of ROS1 gene rearrangement in NSCLC: Results of a meta-analysis

被引：0
|
作者：
Godre, N. [1 ]
Gupta, V. [1 ]
Alam, M. [2 ]
机构：
[1] Pfizer India, Med Affairs Oncol, Mumbai, Maharashtra, India
[2] Pfizer Innovat Hlth, Med Affairs Oncol, Sydney, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
458P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Detection of ALK and ROS1 Rearrangements Using Next Generation Sequencing in Lung Cancer Patients: Comparison Between FISH, IHC and NGS
    Clave, Sergi
    Rodon, Natalia
    Pijuan, Lara
    Dalmases, Alba
    Taus, Alvaro
    Lorenzo, Marta
    Rocha, Pedro
    Munoz-Marmol, Ana M.
    Oliveras, Gloria
    Bosch-Barrera, Joaquim
    Espinet, Blanca
    Bellosillo, Beatriz
    Puig Torrus, Xavier
    Arriola, Edurne
    Salido, Marta
    LABORATORY INVESTIGATION, 2018, 98 : 729 - 729
  • [32] Detection of ALK and ROS1 Rearrangements Using Next Generation Sequencing in Lung Cancer Patients: Comparison Between FISH, IHC and NGS
    Clave, Sergi
    Rodon, Natalia
    Pijuan, Lara
    Dalmases, Alba
    Taus, Alvaro
    Lorenzo, Marta
    Rocha, Pedro
    Munoz-Marmol, Ana M.
    Oliveras, Gloria
    Bosch-Barrera, Joaquim
    Espinet, Blanca
    Bellosillo, Beatriz
    Puig Torrus, Xavier
    Arriola, Edurne
    Salido, Marta
    MODERN PATHOLOGY, 2018, 31 : 729 - 729
  • [33] PON1 is a longevity gene: Results of a meta-analysis
    Lescai, Francesco
    Marchegiani, Francesca
    Franceschi, Claudio
    AGEING RESEARCH REVIEWS, 2009, 8 (04) : 277 - 284
  • [34] Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis
    Huy Gia Vuong
    Thu Quynh Nguyen
    Hoang Cong Nguyen
    Phuoc Truong Nguyen
    An Thi Nhat Ho
    Lewis Hassell
    Targeted Oncology, 2020, 15 : 589 - 598
  • [35] Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis
    Vuong, Huy Gia
    Nguyen, Thu Quynh
    Nguyen, Hoang Cong
    Nguyen, Phuoc Truong
    Ho, An Thi Nhat
    Hassell, Lewis
    TARGETED ONCOLOGY, 2020, 15 (05) : 589 - 598
  • [36] Clinical activity of crizotinib in advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement.
    Shaw, Alice Tsang
    Camidge, D. Ross
    Engelman, Jeffrey A.
    Solomon, Benjamin J.
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Salgia, Ravi
    Shapiro, Geoffrey
    Bang, Yung-Jue
    Tan, Weiwei
    Tye, Lesley
    Wilner, Keith D.
    Stephenson, Patricia
    Varella-Garcia, Marileila
    Bergethon, Kristin
    Iafrate, A. John
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] CLINICAL ACTIVITY OF CRIZOTINIB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) HARBORING ROS1 GENE REARRANGEMENT
    Ou, S. I.
    Camidge, D. R.
    Engelman, J.
    Clark, J.
    Tye, L.
    Wilner, K.
    Stephenson, P.
    Varella-Garcia, M.
    Iafrate, A.
    Shaw, A. T.
    ANNALS OF ONCOLOGY, 2012, 23 : 389 - 389
  • [38] Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a ROS1 Rearrangement: Results from the BRIGAROS StudyBrigatinib for ROS1 NSCLC patientsM. Jean et al.
    Jean Mourlanette
    Gaelle Rousseau-Bussac
    Siham Mallah
    Florian Guisier
    Gerard Zalcman
    Rémi Veillon
    Clarisse Audigier-Valette
    Magali Roa
    Isabelle Nicolle
    Helene Doubre
    Nicolas Cloarec
    Régine Lamy
    Hugues Morel
    Hubert Curcio
    Aurélie Lagrange
    Roland Schott
    Marielle Sabatini
    Anne Claire Toffart
    Julian Pinsolle
    Jaafar Bennouna
    Christos Chouaid
    Julien Mazieres
    Targeted Oncology, 2025, 20 (2) : 311 - 317
  • [39] Detection of lung adenocarcinoma with ROSI rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features
    Cao, Bing
    Wei, Ping
    Liu, Zebing
    Bi, Rui
    Lu, Yongming
    Zhang, Ling
    Zhang, Jing
    Yang, Yusi
    Shen, Chen
    Du, Xiang
    Zhou, Xiaoyan
    ONCOTARGETS AND THERAPY, 2015, 9 : 131 - 138
  • [40] Detection of ALK, ROS1, and RET translocations in non-small cell lung cancer (NSCLC) patients by intragenic differential expression analysis
    Cheng, Shih-Min
    Barlan, Cindy
    Hantash, Feras
    Sanders, Heather R.
    Chan, Patricia H.
    Sulcova, Vladimira
    Sanidad, Marc A.
    Qu, Kevin
    Kelly, Joann C.
    Boyar, Fatih Z.
    Sferruzza, Anthony D.
    Waldman, Frederic M.
    CANCER RESEARCH, 2014, 74 (19)
12345